194 related articles for article (PubMed ID: 18033041)
1. [Phenotype-genotype study in 154 French NF2 mutation carriers].
Demange L; De Moncuit C; Thomas G; Olschwang S
Rev Neurol (Paris); 2007 Nov; 163(11):1031-8. PubMed ID: 18033041
[TBL] [Abstract][Full Text] [Related]
2. Further genotype--phenotype correlations in neurofibromatosis 2.
Selvanathan SK; Shenton A; Ferner R; Wallace AJ; Huson SM; Ramsden RT; Evans DG
Clin Genet; 2010 Feb; 77(2):163-70. PubMed ID: 19968670
[TBL] [Abstract][Full Text] [Related]
3. Cranial meningiomas in 411 neurofibromatosis type 2 (NF2) patients with proven gene mutations: clear positional effect of mutations, but absence of female severity effect on age at onset.
Smith MJ; Higgs JE; Bowers NL; Halliday D; Paterson J; Gillespie J; Huson SM; Freeman SR; Lloyd S; Rutherford SA; King AT; Wallace AJ; Ramsden RT; Evans DG
J Med Genet; 2011 Apr; 48(4):261-5. PubMed ID: 21278391
[TBL] [Abstract][Full Text] [Related]
4. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes.
Kluwe L; Bayer S; Baser ME; Hazim W; Haase W; Fünsterer C; Mautner VF
Hum Genet; 1996 Nov; 98(5):534-8. PubMed ID: 8882871
[TBL] [Abstract][Full Text] [Related]
5. Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities.
Parry DM; MacCollin MM; Kaiser-Kupfer MI; Pulaski K; Nicholson HS; Bolesta M; Eldridge R; Gusella JF
Am J Hum Genet; 1996 Sep; 59(3):529-39. PubMed ID: 8751853
[TBL] [Abstract][Full Text] [Related]
6. Allelic expression of the NF2 gene in neurofibromatosis 2 and schwannomatosis.
Jacoby LB; MacCollin M; Parry DM; Kluwe L; Lynch J; Jones D; Gusella JF
Neurogenetics; 1999 Apr; 2(2):101-8. PubMed ID: 10369886
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value and management of spinal tumors in neurofibromatosis type 2 patients.
Aboukais R; Baroncini M; Zairi F; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 May; 155(5):771-7. PubMed ID: 23381342
[TBL] [Abstract][Full Text] [Related]
8. Intramedullary and spinal canal tumors in patients with neurofibromatosis 2: MR imaging findings and correlation with genotype.
Patronas NJ; Courcoutsakis N; Bromley CM; Katzman GL; MacCollin M; Parry DM
Radiology; 2001 Feb; 218(2):434-42. PubMed ID: 11161159
[TBL] [Abstract][Full Text] [Related]
9. Correlation of nonsense and frameshift mutations with severity of retinal abnormalities in neurofibromatosis 2.
Feucht M; Kluwe L; Mautner VF; Richard G
Arch Ophthalmol; 2008 Oct; 126(10):1376-80. PubMed ID: 18852415
[TBL] [Abstract][Full Text] [Related]
10. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease.
Ruttledge MH; Andermann AA; Phelan CM; Claudio JO; Han FY; Chretien N; Rangaratnam S; MacCollin M; Short P; Parry D; Michels V; Riccardi VM; Weksberg R; Kitamura K; Bradburn JM; Hall BD; Propping P; Rouleau GA
Am J Hum Genet; 1996 Aug; 59(2):331-42. PubMed ID: 8755919
[TBL] [Abstract][Full Text] [Related]
11. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations.
Evans DG; Trueman L; Wallace A; Collins S; Strachan T
J Med Genet; 1998 Jun; 35(6):450-5. PubMed ID: 9643284
[TBL] [Abstract][Full Text] [Related]
12. Genetic Severity Score predicts clinical phenotype in NF2.
Halliday D; Emmanouil B; Pretorius P; MacKeith S; Painter S; Tomkins H; Evans DG; Parry A
J Med Genet; 2017 Oct; 54(10):657-664. PubMed ID: 28848060
[TBL] [Abstract][Full Text] [Related]
13. Intracranial meningiomas and neurofibromatosis type 2.
Aboukais R; Zairi F; Baroncini M; Bonne NX; Schapira S; Vincent C; Lejeune JP
Acta Neurochir (Wien); 2013 Jun; 155(6):997-1001; discussion 1001. PubMed ID: 23558725
[TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study.
Baser ME; Kuramoto L; Joe H; Friedman JM; Wallace AJ; Gillespie JE; Ramsden RT; Evans DG
Am J Hum Genet; 2004 Aug; 75(2):231-9. PubMed ID: 15190457
[TBL] [Abstract][Full Text] [Related]
15. In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to Phenotype.
Heineman TE; Evans DG; Campagne F; Selesnick SH
Otol Neurotol; 2015 Jun; 36(5):908-14. PubMed ID: 25931164
[TBL] [Abstract][Full Text] [Related]
16. Clinical manifestations of mutations in the neurofibromatosis type 2 gene in vestibular schwannomas (acoustic neuromas).
Welling DB
Laryngoscope; 1998 Feb; 108(2):178-89. PubMed ID: 9473065
[TBL] [Abstract][Full Text] [Related]
17. Germline mutations in the neurofibromatosis type 2 tumour suppressor gene.
Bourn D; Carter SA; Mason S; Gareth D; Evans R; Strachan T
Hum Mol Genet; 1994 May; 3(5):813-6. PubMed ID: 8081368
[TBL] [Abstract][Full Text] [Related]
18. Frequency of the Loss of Heterozygosity of the
DE Carvalho RM; DE Castro Sant' Anna C; Pinto GR; Paschoal EHA; Tuji FM; DO Nascimento Borges B; Soares PC; Júnior AGF; Rey JA; Chaves LCL; Burbano RR
Anticancer Res; 2018 Apr; 38(4):2149-2154. PubMed ID: 29599333
[TBL] [Abstract][Full Text] [Related]
19. Clinical and molecular predictors of mortality in neurofibromatosis 2: a UK national analysis of 1192 patients.
Hexter A; Jones A; Joe H; Heap L; Smith MJ; Wallace AJ; Halliday D; Parry A; Taylor A; Raymond L; Shaw A; Afridi S; Obholzer R; Axon P; King AT; ; Friedman JM; Evans DG
J Med Genet; 2015 Oct; 52(10):699-705. PubMed ID: 26275417
[TBL] [Abstract][Full Text] [Related]
20. Calpain-dependent proteolysis of NF2 protein: involvement in schwannomas and meningiomas.
Kimura Y; Saya H; Nakao M
Neuropathology; 2000 Sep; 20(3):153-60. PubMed ID: 11132929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
